Picture BIO Deutschland Corona Special Germany 2020 650x80px
Organisation › Details

Teva (Group)

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. *


Period Start 1994-01-01 existent
Products Industry DRUGS, GENERICS
  Industry 2 pharmaceutical
Persons Person Levin, Jeremy M. (Ovid Therapeutics 202005 CEO + Chairman of BIO before Teva + BMS + Novartis +Cadus)
  Person 2 Sekhri, Paul J. (eGenesis 201901– CEO before Lycera + Sanofi + Teva + TPG Biotech + Cerimon + Ariad + Sprout)
Region Region Petah Tikwa
  Country Israel
  Street 5 Basel St.
  City 49131 Petah Tikva
  Tel +972-3-9267267
    Address record changed: 2019-11-20
Basic data Employees H: 10,001 to 50,00 (2011-09-15)
  Currency USD
  Annual sales 21,903,000,000 (revenues, net, consolidated (2016) 2016-12-31)
  Profit 311,000,000 (2016-12-31)
  Cash 988,000,000 (2016-12-31)
    * Document for �About Section�: Teva Pharmaceutical Industries Ltd.. (11/7/19). "Press Release: Teva Announces Appointment of New Chief Financial Officer". Jerusalem.
Record changed: 2019-11-20


Picture Fairtec GmbH Worldwide Event Solutions 650x65px

More documents for Teva (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top